Abstract
To identify the genetic susceptibility factor(s) for hepatitis C virus–induced hepatocellular carcinoma (HCV-induced HCC), we conducted a genome-wide association study using 432,703 autosomal SNPs in 721 individuals with HCV-induced HCC (cases) and 2,890 HCV-negative controls of Japanese origin. Eight SNPs that showed possible association (P < 1 × 10−5) in the genome-wide association study were further genotyped in 673 cases and 2,596 controls. We found a previously unidentified locus in the 5′ flanking region of MICA on 6p21.33 (rs2596542, Pcombined = 4.21 × 10−13, odds ratio = 1.39) to be strongly associated with HCV-induced HCC. Subsequent analyses using individuals with chronic hepatitis C (CHC) indicated that this SNP is not associated with CHC susceptibility (P = 0.61) but is significantly associated with progression from CHC to HCC (P = 3.13 × 10−8). We also found that the risk allele of rs2596542 was associated with lower soluble MICA protein levels in individuals with HCV-induced HCC (P = 1.38 × 10−13).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J. Clin. Pharmacol. 44, 20–29 (2004).
Parkin, D.M., Bray, F., Ferlay, J. & Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin. 55, 74–108 (2005).
Umemura, T., Ichijo, T., Yoshizawa, K., Tanaka, E. & Kiyosawa, K. Epidemiology of hepatocellular carcinoma in Japan. J. Gastroenterol. 44 (Suppl 19), 102–107 (2009).
Vong, S. & Bell, B.P. Chronic liver disease mortality in the United States, 1990–1998. Hepatology 39, 476–483 (2004).
Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009).
Thomas, D.L. et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461, 798–801 (2009).
Rauch, A. et al. Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 138, 1338–1345, 1345.e1–7 (2010).
Kamatani, Y. et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 41, 591–595 (2009).
Schütte, K., Bornschein, J. & Malfertheiner, P. Hepatocellular carcinoma–epidemiological trends and risk factors. Dig. Dis. 27, 80–92 (2009).
Tanaka, T. et al. Significance of specific antibody assay for genotyping of hepatitis C virus. Hepatology 19, 1347–1353 (1994).
Tanaka, Y. et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat. Genet. 41, 1105–1109 (2009).
Anonymous. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium. Nature 401, 921–923 (1999).
de Bakker, P.I. et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat. Genet. 38, 1166–1172 (2006).
Kuniholm, M.H. et al. Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia. Hepatology 51, 1514–1522 (2010).
Wang, J.H. et al. Ethnic and geographical differences in HLA associations with the outcome of hepatitis C virus infection. Virol. J. 6, 46 (2009).
Singh, R., Kaul, R., Kaul, A. & Khan, K. A comparative review of HLA associations with hepatitis B and C viral infections across global populations. World J. Gastroenterol. 13, 1770–1787 (2007).
Dixon, A.L. et al. A genome-wide association study of global gene expression. Nat. Genet. 39, 1202–1207 (2007).
Ge, D. et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 461, 399–401 (2009).
Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727–729 (1999).
Salih, H.R., Rammensee, H. & Steinle, A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169, 4098–4102 (2002).
Waldhauer, I. et al. Tumor-associated MICA is shed by ADAM proteases. Cancer Res. 68, 6368–6376 (2008).
Jinushi, M. et al. Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J. Hepatol. 43, 1013–1020 (2005).
Groh, V., Wu, J., Yee, C. & Spies, T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734–738 (2002).
Doubrovina, E.S. et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J. Immunol. 171, 6891–6899 (2003).
Kohga, K. et al. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci. 99, 1643–1649 (2008).
Jinushi, M. et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 104, 354–361 (2003).
Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96, 6879–6884 (1999).
Ota, M. et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 49, 448–454 (1997).
Groh, V. et al. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2, 255–260 (2001).
Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl. Acad. Sci. USA 93, 12445–12450 (1996).
Nakamura, Y. The BioBank Japan Project. Clin. Adv. Hematol. Oncol. 5, 696–697 (2007).
Yamaguchi-Kabata, Y. et al. Japanese population structure, based on SNP genotypes from 7003 individuals compared to other ethnic groups: effects on population-based association studies. Am. J. Hum. Genet. 83, 445–456 (2008).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).
Breslow, N. & Day, N. Statistical methods in cancer research. Volume II–The design and analysis of cohort studies. IARC Sci. Publ. 1–406 (1987).
Tsukiyama-Kohara, K. et al. A second group of hepatitis C viruses. Virus Genes 5, 243–254 (1991).
Simmonds, P. et al. Identification of genotypes of hepatitis C virus by sequence comparisons in the core, E1 and NS-5 regions. J. Gen. Virol. 75, 1053–1061 (1994).
Scott, L.J. et al. A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341–1345 (2007).
Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).
Yuan, H.Y. et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 34, W635–W641 (2006).
Acknowledgements
We would like to thank all the subjects and the members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan who donated their DNA for this work. We also thank the technical staff of the Laboratory for Genotyping Development, Center for Genomic Medicine, RIKEN, and the Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, the University of Tokyo. This work was conducted as a part of the BioBank Japan Project that was supported by the Ministry of Education, Culture, Sports, Science and Technology of the Japanese government.
Author information
Authors and Affiliations
Contributions
K.M. and Y.N. conceived of the study; Y.N., V.K., M.K. and K.M. designed the study; V.K., Y.U., R.M. and N.H. performed genotyping; V.K., Y.N. and K.M. wrote the manuscript; A.T. and N. Kamatani performed quality control at the genome-wide phase; Y.N., K.M., H.N. and M.K. managed DNA and serum samples belonging to BioBank Japan; N. Kato, R.T., M. Otsuka, M. Omata and K.K. managed replication DNA and serum samples; V.K. analyzed the data, performed VNTR genotyping, ELISA and summarized the whole results; Y.N. obtained funding for the study.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–10 and Supplementary Tables 1–17. (PDF 1318 kb)
Rights and permissions
About this article
Cite this article
Kumar, V., Kato, N., Urabe, Y. et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet 43, 455–458 (2011). https://doi.org/10.1038/ng.809
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng.809
This article is cited by
-
The immunological role of ADAMs in the field of gastroenterological chronic inflammatory diseases and cancers: a review
Oncogene (2023)
-
Blood DNA methylation and liver cancer in American Indians: evidence from the Strong Heart Study
Cancer Causes & Control (2023)
-
Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer
BMC Cancer (2022)
-
Stat4 rs7574865 polymorphism promotes the occurrence and progression of hepatocellular carcinoma via the Stat4/CYP2E1/FGL2 pathway
Cell Death & Disease (2022)
-
Genetic variants in NKG2D axis and susceptibility to Epstein–Barr virus-induced nasopharyngeal carcinoma
Journal of Cancer Research and Clinical Oncology (2021)